Mutations for the people
Authors
Abstract
Similar cancer types may nevertheless differ widely in the genetic mutations they carry. In this Closeup, Kristensen and Borresen‐Dale discuss how identifying these mutations can define which therapy is most likely to succeed in eliminating the cancerous cells and how the methodology developed by Dias‐Santagata et al and described in this issue, is an important step in making mutation screening a reality in the clinical practice worldwide.
See related article by Dias‐Santagata D et al DOI 10.1002/emmm.201000070
Digital Object Identifier (DOI)
10.1002/emmm.201000071 About DOI
Journal Menu
-
Authors & Referees
